Position
Chief Medical Officer
Company
Iovance Biotherapeutics
San CarlosManufacturingBiotechnologyHealth CareTherapeuticsDescription
Iovance Biotherapeutics has appointed Noah Berkowitz as Chief Medical Officer. Dr. Berkowitz brings extensive experience in drug development and regulatory approvals to support Iovance's TIL platform.
Quick answer
Iovance Biotherapeutics Appoints Noah Berkowitz as Chief Medical Officer (October 2, 2026). Iovance Biotherapeutics is based in San Carlos, California, United States.
- Who is the new Chief Medical Officer at Iovance Biotherapeutics?
- Iovance Biotherapeutics named Noah Berkowitz Chief Medical Officer, announced October 2, 2026.
- What did Iovance Biotherapeutics announce on October 2, 2026?
- Iovance Biotherapeutics has appointed Noah Berkowitz as Chief Medical Officer. Dr. Berkowitz brings extensive experience in drug development and regulatory approvals to support Iovance's TIL platform.
- What does Iovance Biotherapeutics do?
- Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer.
- Where is Iovance Biotherapeutics based?
- Iovance Biotherapeutics is based in San Carlos, California, United States.
- Which similar companies made leadership changes around the same time?
- Jazz Pharmaceuticals plc (October 9, 2026), Gyre Therapeutics (October 22, 2026), XBiotech (October 23, 2026) and AbbVie Inc. (November 2, 2026) also announced leadership changes within 45 days of Iovance Biotherapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Manufacturing
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Jazz Pharmaceuticals Announces Transition in Leadership (October 9, 2026)
- Gyre Therapeutics Appoints Ying Luo as CEO and Thomas Eastling as CFO (October 22, 2026)
- XBiotech Appoints Jan-Paul Simard as Co-Chief Executive Officer (October 23, 2026)
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
- Cerenome Appoints Ron Andrews as Chief Business Officer (November 10, 2026)
- Absci Corporation Appoints Gerry Muhle as Chief Commercial Officer (November 12, 2026)
Who to call at Iovance Biotherapeutics, and when
A new leader at Iovance Biotherapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Iovance Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Iovance Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Iovance Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Iovance Biotherapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Iovance Biotherapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.